72 related articles for article (PubMed ID: 37166421)
1. LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling.
Yu S; Gao X; Liu S; Sha X; Zhang S; Zhang X; Sun D; Jiang X
Cancer Gene Ther; 2024 Apr; 31(4):552-561. PubMed ID: 38267625
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA SNHG20 Suppressed the Proliferation of Cholangiocarcinoma by Sponging miR-520f-3p.
Guan C; Zhao Y; Wang W; Hu Z; Liu L; Li W; Jiang X
Cancer Biother Radiopharm; 2024 Apr; 39(3):178-187. PubMed ID: 32907346
[No Abstract] [Full Text] [Related]
3. Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42.
Liu S; Guan C; Sha X; Gao X; Zou X; Yang C; Zhang X; Zhong X; Jiang X
Cell Signal; 2024 Jun; 118():111141. PubMed ID: 38492624
[TBL] [Abstract][Full Text] [Related]
4. BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma.
Parasramka M; Yan IK; Wang X; Nguyen P; Matsuda A; Maji S; Foye C; Asmann Y; Patel T
Mol Cancer; 2017 Jan; 16(1):22. PubMed ID: 28122578
[TBL] [Abstract][Full Text] [Related]
5. Identification of tumor-suppressive miRNAs that target amino acid transporter LAT1 and exhibit anti-proliferative effects on cholangiocarcinoma cells.
Liu X; Nishikubo K; Ohgaki R; Okanishi H; Okuda S; Xu M; Kanai Y
J Pharmacol Sci; 2024 Apr; 154(4):301-311. PubMed ID: 38485348
[TBL] [Abstract][Full Text] [Related]
6. [LncRNA SOX2OT enhances 5-fluorouracil resistance of cholangiocarcinoma cells by promoting autophagy
Xin C; Wang X; Li X; Chen Y; Wang X; Ning J; Yang S; Wang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):187-193. PubMed ID: 38293991
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.
Pan S; Hu Y; Gan L; Lai J; Zheng P; Zhang Y; Shuai L; Jiang Y; Chen M; Wang J; He Y
Ann Hepatol; 2024; 29(2):101279. PubMed ID: 38123132
[TBL] [Abstract][Full Text] [Related]
8. The real-time dynamic monitoring of microRNA function in cholangiocarcinoma.
Chen X; Chen J; Liu X; Guo Z; Sun X; Zhang J
PLoS One; 2014; 9(6):e99431. PubMed ID: 24918778
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cell-derived exosome-transmitted long non-coding RNA TTN-AS1 can promote the proliferation and migration of cholangiocarcinoma cells.
Zhou X; Kong X; Lu J; Wang H; Liu M; Zhao S; Xia Z; Liu Q; Sun H; Gao X; Ma C; Niu Z; Yang F; Song X; Gao H; Zhang S; Zhu H
J Nanobiotechnology; 2024 Apr; 22(1):191. PubMed ID: 38637832
[TBL] [Abstract][Full Text] [Related]
10. CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression.
Yang B; Zhang J; Wang J; Fan W; Barbier-Torres L; Yang X; Justo MAR; Liu T; Chen Y; Steggerda J; Ramani K; Lu SC; Yang H
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37347224
[TBL] [Abstract][Full Text] [Related]
11. MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1.
Wei Z; Xu B; Yin Y; Chang J; Li Z; Zhang Y; Che X; Bi X
Cancer Cell Int; 2024 Apr; 24(1):129. PubMed ID: 38582841
[TBL] [Abstract][Full Text] [Related]
12. Shoc2 controls ERK1/2-driven neural crest development by balancing components of the extracellular matrix.
Norcross RG; Abdelmoti L; Rouchka EC; Andreeva K; Tussey O; Landestoy D; Galperin E
Dev Biol; 2022 Dec; 492():156-171. PubMed ID: 36265687
[TBL] [Abstract][Full Text] [Related]
13. Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths.
Hjazi A; Jasim SA; Altalbawy FMA; Kaur H; Hamzah HF; Kaur I; Deorari M; Kumar A; Elawady A; Fenjan MN
Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38806965
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNA and Drug resistance in cholangiocarcinoma.
Wu Z; Jiang S; Chen Y
Noncoding RNA Res; 2024 Mar; 9(1):194-202. PubMed ID: 38125756
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W
Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421
[TBL] [Abstract][Full Text] [Related]
16. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
Zhang L; Jiang G; Lu J; Wang L
Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis.
Lu WX
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7356-7368. PubMed ID: 31539122
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
Sun ZP; Tan ZG; Peng C; Yi WM
J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
[TBL] [Abstract][Full Text] [Related]
19. Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma.
Prinz C; Frese R; Grams M; Fehring L
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011390
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
